A rating of 71 puts Humacyte Inc (HUMA) near the top of the Biotechnology industry according to InvestorsObserver. Humacyte Inc's score of 71 means it scores higher than 71% of stocks in the industry. Humacyte Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 69 out of the 148 industries.
HUMA has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on HUMA!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Humacyte Inc Stock Today?
Humacyte Inc (HUMA) stock is higher by 2.38% while the S&P 500 is lower by -1.05% as of 2:16 PM on Thursday, Sep 21. HUMA is higher by $0.07 from the previous closing price of $2.94 on volume of 394,748 shares. Over the past year the S&P 500 has gained 14.94% while HUMA is lower by -17.31%. HUMA lost -$0.86 per share the over the last 12 months.
Click Here to get the full Stock Report for Humacyte Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
